
Back-to-school planning should include medication plan

OIG examines OptionCare's vendor rebates

A pioglitazone (Actos, Takeda) study from Cleveland Clinic shows a reduction in stroke, myocardial infarction and death

ASHP calls proposal "burdensome"

FDA advisory committees vote to keep Trasylol on the market

FDA: No label changes needed for ESA product

New lung cancer guidelines are released from the American College of Chest Physicians.

Patient survival rates improve

Ceftriaxone prescribing information updated to warn of calcium interaction

Abbott notifies patients to check blood glucose display screens.

CMS has released an updated guide to mailings sent to Medicare Part D beneficiaries by prescription drug plans, CMS, or the Social Security Administration.

AmeriHealth offers free one-month generic samples

AmerisourceBergen Technology Group opens new facility in Buffalo Grove, Ill.

Bodee's Zencore Tabs recalled

Sanofi-Aventis settles case alleging the company inflated the average wholesale price to boost profits on its Anzemet.

The number of adverse drug events reported to the FDA has doubled in the past seven years.

Nelfinavir mesylate is found to contain ethyl methanesulfonate.

New Jersey officials have approved the technician-training program developed by Wedgewood Pharmacy, a veterinary compounding pharmacy.

University of California is offering a new two-year postgraduate program in drug development and regulation.

Ninety percent of polled pain care professionals say government regulation impacts their practices.

Poor communication between a health-system's two facilities caused a newborn to be separated from its mother, who has filed a lawsuit as a result.

CMS rejects petition to improve standards for genetic testing.

Natural Products Association believes new vitamin D research could confuse Americans, especially the elderly.

HealthPartners pharmacy has redesigned its Rx labels for greater clarity.

DesignRx and Columbia expand access to progesterone gel for uninsured.

Senate asks CMS to reconsider ESA coverage decision

Data on infection and death rates at New York City's hospitals is being publicly released

With biologic costs zooming, it's time for biogenerics to be approved, says Hospira CEO.

An employer group finds that 13 pharmacy benefit managers are willing to operate transparently in their drug contracting dealings with their clients.

Healthcare report card provides data on quality of hospital care, mortality rates at hospitals in New York and New Jersey.